Usefulness of monitoring of AUC(0-4h) during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation.
Uchida
K
K
Department of Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan.
Tominaga
Y
Y
Haba
T
T
Katayama
T
T
Matsuoka
S
S
Sato
T
T
Goto
N
N
Takeda
A
A
Morozumi
K
K
Takagi
H
H
D019540:Area Under Curve; D001706:Biopsy; D003404:Creatinine / Q000097:blood; D016903:Drug Monitoring / Q000379:methods; D004359:Drug Therapy, Combination; D006085:Graft Survival / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology; D016559:Tacrolimus / Q000097:blood* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D003404:Creatinine; D016559:Tacrolimus